Renal Cell Cancer, Recurrent Terminated Phase 1 / 2 Trials for Isotretinoin (DB00982)

Also known as: Recurrent Renal Cell Cancer

IndicationStatusPhase
DBCOND0082537 (Renal Cell Cancer, Recurrent)Terminated1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00324740Vorinostat and Isotretinoin in Treating Patients With Advanced Kidney CancerTreatment